<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01661361</url>
  </required_header>
  <id_info>
    <org_study_id>S54585</org_study_id>
    <nct_id>NCT01661361</nct_id>
  </id_info>
  <brief_title>Optimalisation of Therapeutic Drug Monitoring (TDM) of Vancomycin in Patients With Central Venous Port Devices</brief_title>
  <official_title>Optimalisation of Therapeutic Drug Monitoring (TDM) of Vancomycin in Patients With Central Venous Port Devices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, it was reported that when vancomycin levels are determined after port sampling,
      levels can be falsely increased potentially leading to wrong dose adjustments.

      The investigators conducted an in vitro experiment using several central venous port devices,
      in which different flushing techniques were evaluated yielding residual vancomycin levels of
      less than 0.5 mg/L.

      In this study, the investigators want to evaluate this flushing technique in vivo in 15
      patients admitted with catheter-related infection and treated with systemic vancomycin and
      vancomycin antibiotic lock.

      The purpose is to assess if correct flushing can avoid spurious vancomycin levels obtained
      via port sampling.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>comparison of central (via port device) and peripherally obtained vancomycin levels: the difference, when using the new flushing technique, is allowed to be maximally 0.5 mg/L</measure>
    <time_frame>central and peripheral vancomycin levels will be obtained during steady state: this means starting from the 4th dose (= day 2) of vancomycin treatment. Vancomycin is usually given during 14 days after the last positive blood culture.</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Catheter-related Infection</condition>
  <arm_group>
    <arm_group_label>vancomycin cohort</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood levels</intervention_name>
    <arm_group_label>vancomycin cohort</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients admitted for catheter related infection with methicillin-resistant
        coagulase-negative staphylococci (MR-CNS) and treated with systemic vancomycin in
        combination with vancomycin antibiotic lock via central venous port device.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients,

          -  having central venous port device,

          -  treated with systemic vancomycin in combination with vancomycin antibiotic lock

        Exclusion Criteria:

          -  pregnant women,

          -  children,

          -  patients with 'do not resuscitate' (DNR) code
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabel Spriet, PharmD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pharmacy Dpt, University Hospitals Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jan Verhaegen, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical Diagnostic Sciences, University Hospitals Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hans Prenen, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Digestive ONcology, University Hosptials Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Willy Peetermans, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Internal Medicine, University Hospitals Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ludo Willems, PharmD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Pharmacy Dpt., University Hosptials Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabel Spriet, PharmD PhD</last_name>
    <phone>0032 16 34 30 80</phone>
    <email>isabel.spriet@uzleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jan Verhaegen, MD PhD</last_name>
    <phone>0032 16 33 22 11</phone>
    <email>jan.verhaegen@uzleuven.be</email>
  </overall_contact_backup>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2012</study_first_submitted>
  <study_first_submitted_qc>August 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2012</study_first_posted>
  <last_update_submitted>August 8, 2012</last_update_submitted>
  <last_update_submitted_qc>August 8, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Isabelle Spriet</investigator_full_name>
    <investigator_title>PharmD, PhD</investigator_title>
  </responsible_party>
  <keyword>vancomycin</keyword>
  <keyword>levels</keyword>
  <keyword>central venous port device</keyword>
  <keyword>peripherally obtained levels</keyword>
  <keyword>dose adjustments</keyword>
  <keyword>TDM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Catheter-Related Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

